Head and Neck Neoplasms
1 competing product in clinical development for Head and Neck Neoplasms.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Patritumab + Cetuximab + Cisplatin + Carboplatin + Placebo | Daiichi Sankyo | Phase 2 | Terminated | 27 |